OXBOF.US Oxford BioDynamics Plc

Healthcare Biotechnology USA Stocks
0.0030 USD
Close of Nov 15, 2026
0.0014 0.0042
Market cap
USD 40.3M
P/E
-
P/B
9.34x
ROE
-549.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is OXBOF.US undervalued?

Graham number

The Graham number of Oxford BioDynamics Plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Oxford BioDynamics Plc fundamental analysis

No fundamental analysis for Oxford BioDynamics Plc yet.

Oxford BioDynamics Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Oxford BioDynamics Plc

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screenin…

Full company profile